NeoGenomics (NEO) Prices 3.15M Shares at $3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Join SI Premium – FREE
NeoGenomics, Inc. (NASDAQ: NEO) priced an underwritten public offering of 3.15 million shares of common stock at a price to the public of $3.00 per share.
Of the shares offered, NeoGenomics is selling 2.85 million shares and a selling stockholder, The Mary S. Dent Gifting Trust, is selling 300,000 shares.
Craig-Hallum Capital Group LLC is the book-running manager for the offering with Ladenburg Thalmann & Co. Inc. and Emerging Growth Equities, Ltd. serving as co-managers on the offering.
Of the shares offered, NeoGenomics is selling 2.85 million shares and a selling stockholder, The Mary S. Dent Gifting Trust, is selling 300,000 shares.
Craig-Hallum Capital Group LLC is the book-running manager for the offering with Ladenburg Thalmann & Co. Inc. and Emerging Growth Equities, Ltd. serving as co-managers on the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler: 'Neogenomics (NEO) Is Winning the Community'
- BTIG Upgrades Neogenomics (NEO) to Buy
- China SXT Pharmaceuticals closes $12M registered direct offering
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
